Cocrystal Formation during Cogrinding and Storage is Mediated by Amorphous Phase

PurposeThe purpose of this work was to investigate the mechanisms of cocrystal formation during cogrinding and storage of solid reactants, and to establish the effects of water by cogrinding with hydrated form of reactants and varying RH conditions during storage.MethodsThe hydrogen bonded 1:1 carbamazepine–saccharin cocrystal (CBZ–SAC) was used as a model compound. Cogrinding of solid reactants was studied under ambient and cryogenic conditions. The anhydrous, CBZ (III), and dihydrate forms of CBZ were studied. Coground samples were stored at room temperature at 0% and 75% RH. Samples were analyzed by XRPD, FTIR and DSC.ResultsCocrystals prepared by cogrinding and during storage were similar to those prepared by solvent methods. The rate of cocrystallization was increased by cogrinding the hydrated form of CBZ and by increasing RH during storage. Cryogenic cogrinding led to higher levels of amorphization than room temperature cogrinding. The amorphous phase exhibited a Tg around 41°C and transformed to cocrystal during storage.ConclusionsAmorphous phases generated by pharmaceutical processes lead to cocrystal formation under conditions where there is increased molecular mobility and complementarity. Water, a potent plasticizer, enhances the rate of cocrystallization. This has powerful implications to control process induced transformations.

[1]  Z. Urbańczyk-Lipkowska,et al.  Hydrogen Bond Directed Cocrystallization and Molecular Recognition Properties of Diarylureas , 1991 .

[2]  G. Zografi,et al.  Effects of sorbed water on the crystallization of indomethacin from the amorphous state. , 1997, Journal of pharmaceutical sciences.

[3]  Margaret C. Etter,et al.  Hydrogen-bond directed cocrystallization as a tool for designing acentric organic solids , 1989 .

[4]  J. McMahon,et al.  Crystal engineering of the composition of pharmaceutical phases. , 2003, Chemical communications.

[5]  A. Matzger,et al.  General Principles of Pharmaceutical Solid Polymorphism. A Supramolecular Perspective , 2004 .

[6]  D. Brooke,et al.  Heat of fusion measurement of a low melting polymorph of carbamazepine that undergoes multiple-phase changes during differential scanning calorimetry analysis. , 1991, Journal of pharmaceutical sciences.

[7]  Michael J Cima,et al.  High-throughput crystallization: polymorphs, salts, co-crystals and solvates of pharmaceutical solids. , 2004, Advanced drug delivery reviews.

[8]  G Zografi,et al.  A study of amorphous molecular dispersions of indomethacin and its sodium salt. , 2001, Journal of pharmaceutical sciences.

[9]  G. Desiraju,et al.  Supramolecular Structures – Reason and Imagination , 1998 .

[10]  S. Reutzel,et al.  Hydrogen Bond Directed Cocrystallization and Molecular Recognition Properties of Acyclic Imides , 1991 .

[11]  F. Miller,et al.  Course Notes on the Interpretation of Infrared and Raman Spectra , 2004 .

[12]  Amid Salari,et al.  Application of attenuated total reflectance FTIR spectroscopy to the analysis of mixtures of pharmaceutical polymorphs , 1998 .

[13]  M. Otsuka,et al.  Effect of environmental humidity on the transformation pathway of carbamazepine polymorphic modifications during grinding , 1999 .

[14]  N Kaneniwa,et al.  Effect of environmental temperature on polymorphic solid-state transformation of indomethacin during grinding. , 1986, Chemical & pharmaceutical bulletin.

[15]  S. Limmatvapirat,et al.  Elucidation of solid-state complexation in ground mixtures of cholic acid and guest compounds. , 2002, Chemical & pharmaceutical bulletin.

[16]  H. A. Schneider,et al.  The Gordon‐Taylor equation. Additivity and interaction in compatible polymer blends , 1988 .

[17]  G. Jovanovski.  Metal Saccharinates and Their Complexes with N-donor Ligands , 2000 .

[18]  Sarah J. Nehm,et al.  Phase solubility diagrams of cocrystals are explained by solubility product and solution complexation , 2006 .

[19]  Richard C. Lord,et al.  Introduction to Infrared and Raman Spectroscopy. , 1965 .

[20]  M. Caira,et al.  Structure and solid-state chemistry of anhydrous and hydrated crystal forms of the trimethoprim-sulfamethoxypyridazine 1:1 molecular complex. , 2000, Journal of pharmaceutical sciences.

[21]  E. Yonemochi,et al.  Specific Complexation of Ursodeoxycholic Acid with Guest Compounds Induced by Co-grinding. II. Effect of Grinding Temperature on the Mechanochemical Complexation , 2003 .

[22]  S. Hoag,et al.  Influence of various drugs on the glass transition temperature of poly(vinylpyrrolidone): a thermodynamic and spectroscopic investigation. , 2001, International journal of pharmaceutics.

[23]  William Jones,et al.  Solvent-drop grinding: green polymorph control of cocrystallisation. , 2004, Chemical communications.

[24]  M. C. Etter,et al.  Using hydrogen bonds to design acentric organic materials for nonlinear optical users , 1990 .

[25]  B. Spong.  Enhancing the pharmaceutical behavior of poorly soluble drugs through the formation of cocrystals and mesophases. , 2005 .

[26]  W. Jones,et al.  Crystal Engineering of Organic Cocrystals by the Solid-State Grinding Approach , 2005 .

[27]  Sarah J. Nehm,et al.  Reaction crystallization of pharmaceutical molecular complexes. , 2006, Molecular pharmaceutics.

[28]  R. Bogner,et al.  Formation of physically stable amorphous drugs by milling with Neusilin. , 2003, Journal of pharmaceutical sciences.

[29]  Gautam R Desiraju,et al.  Hydrogen bridges in crystal engineering: interactions without borders. , 2002, Accounts of chemical research.

[30]  Christer B. Aakeröy,et al.  Building co-crystals with molecular sense and supramolecular sensibility , 2005 .

[31]  F. O'Brien.  The Control of Humidity by Saturated Salt Solutions , 1948 .

[32]  S. Teleb.  Spectral and thermal studies ofsaccharinato complexes , 2004 .

[33]  S. Reutzel,et al.  Self-organization of adenine and thymine in the solid state , 1993 .

[34]  M. Kemper,et al.  Quantitative analysis of polymorphs in binary and multi-component powder mixtures by near-infrared reflectance spectroscopy. , 2000, International journal of pharmaceutics.

[35]  M. Caira,et al.  Selective formation of hydrogen bonded cocrystals between a sulfonamide and aromatic carboxylic acids in the solid state , 1995 .

[36]  G. Zografi,et al.  Cryogenic grinding of indomethacin polymorphs and solvates: assessment of amorphous phase formation and amorphous phase physical stability. , 2002, Journal of pharmaceutical sciences.

[37]  M. Caira.  Molecular complexes of sulfonamides. 2.1:1 complexes between drug molecules: sulfadimidine-acetylsalicylic acid and sulfadimidine-4-aminosalicylic acid , 1992 .

[38]  Bruno C. Hancock,et al.  The Relationship Between the Glass Transition Temperature and the Water Content of Amorphous Pharmaceutical Solids , 1994, Pharmaceutical Research.

[39]  E. Yonemochi,et al.  Specific complexation of ursodeoxycholic acid with guest compounds induced by co-grinding , 2000 .

[40]  William Jones,et al.  Pharmaceutical Cocrystallization: Engineering a Remedy for Caffeine Hydration , 2005 .

[41]  Bruno C. Hancock,et al.  Molecular Mobility of Amorphous Pharmaceutical Solids Below Their Glass Transition Temperatures , 1995, Pharmaceutical Research.

[42]  B. Šoptrajanov,et al.  The SO2 Stretching Vibrations in Some Metal Saccharinates: Spectra-Structure Correlations , 1995 .

[43]  R. Docherty,et al.  Creation of crystalline supramolecular arrays: a comparison of co-crystal formation from solution and by solid-state grinding , 1996 .

[44]  Y. Hase.  The infrared and Raman spectra of phthalimide, N-d-phthalimide and potassium phthalimide , 1978 .

[45]  Lynne S. Taylor,et al.  Spectroscopic Characterization of Interactions Between PVP and Indomethacin in Amorphous Molecular Dispersions , 1997, Pharmaceutical Research.

[46]  Margaret C. Etter,et al.  Hydrogen bonds as design elements in organic chemistry , 1991 .

[47]  N. Rodríguez-Hornedo,et al.  Solution-mediated phase transformation of anhydrous to dihydrate carbamazepine and the effect of lattice disorder. , 2002, International journal of pharmaceutics.